Efficacy and Safety of Sofosbuvir Containing Regimens for the Treatment of Chronic HCV Infection in Participants With Chronic Genotype 1, 2, 3, or 6 HCV Infection

Mise à jour : Il y a 4 ans
Référence : NCT01826981

Femme et Homme

  • | Pays :
  • New Zealand
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The purpose of this study is to evaluate the antiviral efficacy, safety, tolerability of combination therapy with sofosbuvir (SOF) containing regimens for the treatment of chronic hepatitis C virus (HCV) infection.


Critère d'inclusion

  • Chronic hepatitis C

Liens